HALO (US) share price forecast & AI signal — Halozyme Therapeutics, Inc
Week of 2026-10-30 · Healthcare
Exact confidence, 1-week / 1-month / 3-month breakdown, plain-English AI write-up, bull-vs-bear debate, support & resistance.
Get 5 free tokens — no card Already a member? Open the full analysisWhat the model sees in HALO
Halozyme Therapeutics, Inc is a Healthcare stock listed on the US. For the week of 2026-10-30 the ACE machine-learning model rates it a BUY with low confidence, based on technical indicators and the stock's own historical patterns across three time horizons. The direction is updated every model run.
About Halozyme Therapeutics, Inc
Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. It offers Hylenex recombinant, a formulation of rHuPH20 that facilitates subcutaneous (SC) administration to enhance the dispersion and absorption of other injected drugs in SC urography and to enhance resorption of radiopaque agents; and...
Recent closes
| Date | Close |
|---|---|
| 2026-11-06 | $103.63 |
| 2026-11-05 | $122.96 |
| 2026-11-04 | $130.34 |
| 2026-11-03 | $128.62 |
| 2026-11-02 | $128.95 |
| 2026-10-30 | $130.91 |
| 2026-10-29 | $131.18 |
HALO FAQ
Is Halozyme Therapeutics, Inc (HALO) a buy or sell this week?
The ACE Stock Bots machine-learning model rates HALO a BUY for the week of 2026-10-30 with low confidence. The exact confidence and the 1-week, 1-month and 3-month breakdown are free with a signup (5 analysis tokens, no card).
What is the AI share price forecast for HALO?
Every week the model scores HALO across three horizons using technical indicators and the stock's own historical patterns. An AI then writes a plain-English summary with support and resistance levels, and a bull analyst and a bear analyst argue the case.
Is this financial advice?
No. ACE Stock Bots provides general information generated by software. It does not consider your objectives, financial situation or needs. Read the disclaimer and consider licensed advice before acting.
Other Healthcare stocks on the US
This week's top US picks · All US stocks
Signals are generated by software for general information only and are not a recommendation to buy or sell. See the disclaimer.